Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group

MA Bergmann; ME Goebeler; M Herold; B Emmerich; Martin Wilhelm; C Ruelfs; L Boening; MJ Hallek

Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group

MA Bergmann, ME Goebeler, M Herold, B Emmerich, Martin Wilhelm (Co-author), C Ruelfs, L Boening, MJ Hallek

Research output: Contribution to journal › Original Article › peer-review

Original language	English
Pages (from-to)	1357-1364
Journal	HAEMATOLOGICA
Volume	90
Issue number	10
Publication status	Published - 2005

Keywords

PROGRESSIVE SOLID TUMORS
DIAGNOSIS

Cite this

Bergmann, MA., Goebeler, ME., Herold, M., Emmerich, B., Wilhelm, M., Ruelfs, C., Boening, L., & Hallek, MJ. (2005). Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group. HAEMATOLOGICA , 90(10), 1357-1364.

Bergmann, MA ; Goebeler, ME ; Herold, M et al. / Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group. In: HAEMATOLOGICA 2005 ; Vol. 90, No. 10. pp. 1357-1364.

@article{819aa64e2baf41648088534479d70bde,

title = "Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group",

keywords = "PROGRESSIVE SOLID TUMORS, DIAGNOSIS",

author = "MA Bergmann and ME Goebeler and M Herold and B Emmerich and Martin Wilhelm and C Ruelfs and L Boening and MJ Hallek",

year = "2005",

language = "English",

volume = "90",

pages = "1357--1364",

journal = "HAEMATOLOGICA ",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "10",

}

Bergmann, MA, Goebeler, ME, Herold, M, Emmerich, B, Wilhelm, M, Ruelfs, C, Boening, L & Hallek, MJ 2005, 'Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group', HAEMATOLOGICA , vol. 90, no. 10, pp. 1357-1364.

Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group. / Bergmann, MA; Goebeler, ME; Herold, M et al.
In: HAEMATOLOGICA , Vol. 90, No. 10, 2005, p. 1357-1364.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group

AU - Bergmann, MA

AU - Goebeler, ME

AU - Herold, M

AU - Emmerich, B

AU - Wilhelm, Martin

AU - Ruelfs, C

AU - Boening, L

AU - Hallek, MJ

PY - 2005

Y1 - 2005

KW - PROGRESSIVE SOLID TUMORS

KW - DIAGNOSIS

M3 - Original Article

C2 - 16219572

SN - 0390-6078

VL - 90

SP - 1357

EP - 1364

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

IS - 10

ER -

Bergmann MA, Goebeler ME, Herold M, Emmerich B, Wilhelm M, Ruelfs C et al. Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group. HAEMATOLOGICA . 2005;90(10):1357-1364.